Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Markers ; 2022: 5106342, 2022.
Article in English | MEDLINE | ID: mdl-35096202

ABSTRACT

OBJECTIVE: An outbreak of coronavirus disease-19 (COVID-19) began in December 2019 and spread globally, overwhelming the entire world. COVID-19 is a public health emergency of international concern. Due to its high morbidity and mortality rate, recognition of its risk and prognostic factors is important. We aimed to understand the relationship between metabolic and endocrine parameters and the prognosis of COVID-19. METHODS AND MATERIALS: This was a cross-sectional clinical study. A total of 70 patients with severe COVID-19 were enrolled. Laboratory results at the first admission time (including complete blood count, C-reactive protein, lactate dehydrogenase, blood glucose, calcium, phosphate, albumin, creatinine, magnesium, lipid profiles, liver enzymes, thyroid hormones, cortisol, and vitamin D) and outcome data were recorded. We divided patients into (1) intensive care unit- (ICU-) admitted and non-ICU-admitted and (2) survivors and nonsurvivors for estimation of severity and prognosis. We determined the risk factors associated with critical illness and poor prognosis. RESULTS: Patients with higher white blood cell (WBC) count and phosphate levels had significantly higher ICU admission rates. According to univariate analysis, serum levels of T3, phosphate, and WBC as well as the duration of hospitalization were associated with mortality. Multivariate analysis revealed that only WBC and duration of hospitalization were independent predictors for mortality rate in COVID-19 patients. CONCLUSION: Our findings suggest that longer duration of hospitalization and higher WBC count are associated with poor outcomes in patients with COVID-19.


Subject(s)
COVID-19/etiology , COVID-19/mortality , Endocrine System/metabolism , Leukocyte Count , Phosphates/blood , Aged , Biomarkers , Blood Chemical Analysis , Cross-Sectional Studies , Endocrine System/virology , Female , Humans , Intensive Care Units , Length of Stay , Male , Middle Aged , Mortality , Multivariate Analysis , Prognosis , Severity of Illness Index , Vitamin D/blood
2.
Physiol Res ; 70(S2): S153-S159, 2021 12 16.
Article in English | MEDLINE | ID: mdl-34913349

ABSTRACT

Aged people are the most susceptible group to COVID-19 infection. Immunosenescence characterized by impairment of immune function with inflamm-aging contributes to pathophysiological alterations, among which endocrine and metabolic diseases are not exception. Diabetes, obesity along with impairment of disorders of thyroid functions are the most frequent ones, the common feature of which is failure of immune system including autoimmune processes. In the minireview we discussed how COVID-19 and aging impact innate and adaptive immunity, diabetes and selected neuroendocrine processes. Mentioned is also beneficial effect of vitamin D for attenuation of these diseases and related epigenetic issues. Particular attention is devoted to the role of ACE2 protein in the light of its intimate link with renin-angiotensin regulating system.


Subject(s)
Aging/metabolism , COVID-19/metabolism , Endocrine System/metabolism , Renin-Angiotensin System , SARS-CoV-2/pathogenicity , Adaptive Immunity , Age Factors , Aging/immunology , Animals , COVID-19/immunology , COVID-19/physiopathology , COVID-19/virology , Endocrine System/immunology , Endocrine System/physiopathology , Endocrine System/virology , Host-Pathogen Interactions , Humans , Immunity, Innate , Immunosenescence , SARS-CoV-2/immunology
3.
Sci Rep ; 11(1): 2562, 2021 01 28.
Article in English | MEDLINE | ID: mdl-33510449

ABSTRACT

The relationship between viral infection and obesity has been known for several decades but epidemiological data is limited to only a few viral pathogens. The association between obesity and a wide range of viruses was assessed using VirScan, a pan-viral serological profiling tool. Serum specimens from 457 Qatari adults (lean = 184; obese = 273) and 231 Qatari children (lean = 111; obese = 120) were analyzed by VirScan. Associations with obesity were determined by odds ratio (OR) and Fisher's test (p values), and by multivariate regression analysis to adjust for age and gender. Although there was no association of viral infections with obesity in the pediatric population, a nominal association of obesity with seropositivity to members of the Herpesviridae family is observed for the adult population (OR = 1.5-3.3; p < 0.05). After adjusting p values for multiple comparisons (Bonferroni correction) the odds of being obese is significantly higher in herpes simplex virus 1 (HSV-1) seropositive Qatari adults (OR = 3.3; 95% CI 2.15-4.99; p = 2.787E - 08). By VirScan, the sero-prevalence of HSV1 is 81.3% and 57.1% among Qatari obese and lean adult populations, respectively. Higher prevalence of antibodies against several peptide epitopes of HSV-1/2 is positively associated with obesity (OR = 2.35-3.82; p ≤ 3.981E - 05). By multivariate regression analysis, HSV-1 was independently associated with obesity irrespective of age and gender. Our results suggest that obesity among Qataris may be associated with a higher prevalence of herpesvirus infections, in particular HSV-1. Furthermore, the high prevalence of antibodies against peptide antigens specific to HSV-1 and -2 in the obese population suggests that these viral peptides may play a role in adipogenesis. Further studies with these candidate peptides in cell culture or animal models may confirm their adipogenic roles.


Subject(s)
Obesity/metabolism , Obesity/virology , Virome/physiology , Adult , Endocrine System/metabolism , Endocrine System/virology , Female , Herpesviridae/genetics , Herpesviridae/pathogenicity , Humans , Male , Metabolic Diseases/metabolism , Metabolic Diseases/virology , Middle Aged , Virology/methods , Virome/genetics
4.
Nat Clin Pract Endocrinol Metab ; 5(1): 26-34, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19079271

ABSTRACT

Chronic infection with hepatitis C virus (HCV) can result in both hepatic and extrahepatic disease and endocrine dysfunction represents an important class of HCV-related extrahepatic disease. The most frequently occurring--and clinically important--of these endocrine disorders are thyroid disease and type 2 diabetes mellitus. In this Review, we evaluate the evidence in support of a link between HCV infection and endocrine-system dysfunction, and discuss potential pathophysiological mechanisms. A meta-analysis of the literature has revealed significant associations between chronic HCV infection, thyroid autoimmunity and hypothyroidism. Furthermore, a high prevalence of thyroid cancer has been reported in HCV-positive patients. Several clinicoepidemiological studies have demonstrated that chronic HCV infection could lead to the development of type 2 diabetes mellitus, possibly as a result of HCV-induced metabolic disturbances. Some researchers have postulated that a type 1 T-helper -cell mediated immune response underpins the association of chronic HCV infection with endocrine disease. Indeed, the available data suggest that a common immunological, type 1 T-helper cell pattern of cytokine expression and activation (via interferon-gamma) could provide the pathophysiological basis for this association. Nonetheless, additional studies will be necessary to elucidate fully all the mechanisms involved in HCV-related endocrine dysfunction.


Subject(s)
Endocrine System/pathology , Endocrine System/virology , Hepacivirus/physiology , Hepacivirus/pathogenicity , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/pathology , Diabetes Mellitus, Type 2/virology , Humans , Thyroid Diseases/etiology , Thyroid Diseases/pathology , Thyroid Diseases/virology , Thyroid Neoplasms/etiology , Thyroid Neoplasms/pathology , Thyroid Neoplasms/virology
5.
Cytogenet Genome Res ; 105(2-4): 351-62, 2004.
Article in English | MEDLINE | ID: mdl-15237223

ABSTRACT

Endogenous retroviruses (ERVs) are stably integrated in the genome of vertebrates and inherited as Mendelian genes. The several human ERV (HERV) families and related elements represent up to 5-8% of the DNA of our species. ERVs may be involved in the regulation of adjacent genomic loci, especially promoting the tissue-specific expression of genes; some HERVs may have functional roles, e.g., coding for the placental fusogenic protein, syncytin. This paper reviews the growing evidence about factors that may modulate ERVs, including: cell and tissue types (with special attention to placenta and germ cells), processes related to differentiation and aging, cytokines, agents that disrupt cell functions (e.g., DNA hypomethylating agents) and steroids. Special attention is given to HERVs, due to their possible involvement in autoimmunity and reproduction, as well as altered expression in some cancer types; moreover, different HERV families may deserve specific attention, due to remarkable differences concerning, e.g., expression in tissues. A comparison with factors interacting with murine ERV-related sequences indicates that the mouse may be a useful model for studying some patterns of HERV regulation. Overall, the available evidence identifies the diverse, potential interactions with endogenous or exogenous factors as a promising field for investigating the roles of ERVs in physiology and disease.


Subject(s)
Endogenous Retroviruses/physiology , Animals , Endocrine System/virology , Endogenous Retroviruses/drug effects , Endogenous Retroviruses/genetics , Endogenous Retroviruses/immunology , Environment , Humans , Immunity , Mice , Neoplasms/virology
SELECTION OF CITATIONS
SEARCH DETAIL